» Authors » Vivek Misra

Vivek Misra

Explore the profile of Vivek Misra including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 48
Citations 791
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Reddy S, Garg T, Shah C, Nascimento F, Imran R, Kan P, et al.
Case Rep Neurol . 2020 Jul; 12(2):199-209. PMID: 32647526
COVID-19 has been associated with a hypercoagulable state causing cardiovascular and neurovascular complications. To further characterize cerebrovascular disease (CVD) in COVID-19, we review the current literature of published cases and...
12.
Burns V, Misra V, Paton N
Br J Nurs . 2020 May; 29(10):S22-S29. PMID: 32463747
The Christie NHS Foundation Trust is a leader in adapting patient care in response to treatment advances and new patient-centred care/efficiency initiatives. Due to extended waiting times in cancer clinics,...
13.
Chiu D, McCane C, Lee J, John B, Nguyen L, Butler K, et al.
J Stroke Cerebrovasc Dis . 2020 Apr; 29(6):104816. PMID: 32321651
Background And Purpose: Repetitive transcranial magnetic stimulation (rTMS) may promote recovery of motor function after stroke by inducing functional reorganization of cortical circuits. The objective of this study was to...
14.
Hoskin P, Hopkins K, Misra V, Holt T, McMenemin R, Dubois D, et al.
JAMA . 2019 Dec; 322(21):2084-2094. PMID: 31794625
Importance: Malignant spinal canal compression, a major complication of metastatic cancer, is managed with radiotherapy to maintain mobility and relieve pain, although there is no standard radiotherapy regimen. Objective: To...
15.
Berekashvili K, Soomro J, Shen L, Misra V, Chen P, Blackburn S, et al.
J Stroke Cerebrovasc Dis . 2018 Sep; 27(12):3647-3651. PMID: 30249518
Background: A randomized trial of concurrent recombinant tissue-type plasminogen activator (r-tPA) + thrombin-inhibition with Argatroban in stroke patients recently demonstrated safety and signal of efficacy compared to r-tPA alone, but...
16.
Di Napoli M, Behrouz R, Topel C, Misra V, Pomero F, Giraudo A, et al.
J Crit Care . 2017 Jun; 41:247-253. PMID: 28599198
Purpose: Hypoalbuminemia and systemic inflammatory response syndrome (SIRS) are reported in critically-ill patients, but their relationship is unclear. We sought to determine the association of admission serum albumin and SIRS...
17.
Huang L, Liu Y, Lu J, Cerqueira B, Misra V, Duong T
Stem Cell Res Ther . 2017 Mar; 8(1):74. PMID: 28330501
Background: Human umbilical cord blood (hUCB) cell therapy is a promising treatment for ischemic stroke. The effects of hyperacute stem cell transplantation on cerebrovascular function in ischemic stroke are, however,...
18.
Behrouz R, Misra V, Godoy D, Topel C, Masotti L, Klijn C, et al.
J Stroke Cerebrovasc Dis . 2017 Feb; 26(6):1216-1221. PMID: 28169096
Background And Purpose: Intracerebral hemorrhage (ICH) volume, particularly if ≥30 mL, is a major determinant of poor outcome. We used a multinational ICH data registry to study the characteristics, course,...
19.
Behrouz R, Birnbaum L, Jones P, Topel C, Misra V, Rabinstein A
J Stroke Cerebrovasc Dis . 2016 Aug; 25(11):2644-2647. PMID: 27480818
Background And Aim: Focal neurological deficit (FND) is a recognized presenting symptom of aneurysmal subarachnoid hemorrhage (SAH). However, little is known on how often aneurysmal SAH patients present with FND...
20.
Birnbaum L, Rodriguez J, Topel C, Behrouz R, Misra V, Palacio S, et al.
J Stroke Cerebrovasc Dis . 2016 Aug; 25(11):2668-2672. PMID: 27476342
Introduction: The timely administration of intravenous (IV) tissue plasminogen activator (t-PA) to acute ischemic stroke patients from the period of symptom presentation to treatment, door-to-needle (DTN) time, is an important...